Skip to content
Dipyrone
Dipyrone is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02B: Other analgesics and antipyretics in atc
— N02BB: Pyrazolones, analgesics and antipyretics
— N02BB02: Metamizole sodium
— N02BB52: Metamizole sodium, combinations excl. psycholeptics
— N02BB72: Metamizole sodium, combinations with psycholeptics
HCPCS
No data
Clinical
Clinical Trials
45 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149G89.18—235515
PainD010146EFO_0003843R52—11417
Cesarean sectionD002585———3—3
NeuralgiaD009437EFO_0009430———2—2
Pain managementD059408———1—1
AnesthesiaD000758———1—1
Hip fracturesD006620EFO_0003964S72.00———1—1
FeverD005334HP_0001945R50.9———1—1
Abdominal aortic aneurysmD017544EFO_0004214———1—1
Atherosclerotic plaqueD058226HP_0031678I70———1—1
Show 3 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic painD059350HP_0012532—11——2
Migraine disordersD008881EFO_0003821G43——1——1
Spinal cord injuriesD013119EFO_1001919——1——1
GastroenteritisD005759EFO_1001463K52.9——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acute painD059787R52—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug interactionsD0043472————2
Healthy volunteers/patients—1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gingival recessionD005889K06.0————33
Postoperative nausea and vomitingD020250EFO_0004888————22
Vitreoretinal surgeryD057586————22
AnalgesiaD000698————22
Tooth abrasionD014072K03.1————22
Intervertebral disc degenerationD055959HP_0008419————11
Platelet aggregationD010974GO_0070527————11
CraniotomyD003399————11
AnxietyD001007EFO_0005230F41.1————11
Chronic pancreatitisD050500EFO_0000342K86.1————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDIPYRONE
INNmetamizole sodium
Description
Metamizole sodium is an organic sodium salt of antipyrine substituted at C-4 by a methyl(sulfonatomethyl)amino group, commonly used as a powerful analgesic and antipyretic. It has a role as a non-narcotic analgesic, an antirheumatic drug, a peripheral nervous system drug, an antipyretic, a prodrug, a cyclooxygenase 3 inhibitor and an anti-inflammatory agent. It contains a metamizole(1-).
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]
Identifiers
PDB—
CAS-ID68-89-3
RxCUI1537943
ChEMBL IDCHEMBL3989803
ChEBI ID—
PubChem CID522325
DrugBankDB04817
UNII IDVSU62Z74ON (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2,167 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
20,411 adverse events reported
View more details